FRI-2 carbapenemase-producing Enterobacter cloacae complex in the UK | Zendy

Danièle Meunier | Zendy; Jacqueline Findlay | Zendy; Michel Doumith | Zendy; Daniel Godoy | Zendy; Claire Perry | Zendy; Rachel Pike | Zendy; Firza Alexander Gronthoud | Zendy; Theresa Shryane | Zendy; Laurent Poirel | Zendy; William Welfare | Zendy; Neil Woodford | Zendy; Katie L. Hopkins | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

FRI-2 carbapenemase-producing Enterobacter cloacae complex in the UK

Author(s) -

Danièle Meunier,

Jacqueline Findlay,

Michel Doumith,

Daniel Godoy,

Claire Perry,

Rachel Pike,

Firza Alexander Gronthoud,

Theresa Shryane,

Laurent Poirel,

William Welfare,

Neil Woodford,

Katie L. Hopkins

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx173

Subject(s) - enterobacter cloacae , ertapenem , meropenem , microbiology and biotechnology , carbapenem , imipenem , biology , klebsiella pneumoniae , tazobactam , agar dilution , piperacillin , gene , antimicrobial , pseudomonas aeruginosa , antibiotic resistance , bacteria , minimum inhibitory concentration , genetics , antibiotics , escherichia coli

Detection of rarer carbapenemases is challenging, as it requires molecular assays with comprehensive coverage or the use of phenotypic methods for the detection of carbapenemase activity. We describe a new class A carbapenemase, FRI-2, in an Enterobacter cloacae complex isolate following implementation of an in-house multiplex PCR for the detection of 'rare' class A carbapenemases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research